Furthermore, double immunofluorescence staining showed that the phosphorylation of TBK1 in EpCam+ tumor cells in the combined treatment group was much higher than that in the control group and the monotherapy group (Figure 7F; and Figure S7C, Supporting Information). The gene discussed is EPCAM; the disease is neoplasm.